Supportive Care Clinical Trials
Preventing Anthracycline Cardiovascular Toxicity with Statins (PREVENT)
The purpose of this research study is to see if Atorvastatin (generic for Lipitor) 40 mg by mouth daily decreases the chance of developing heart problems in participants receiving anthracycline based chemotherapy for breast cancer or lymphoma.
Status: Accepting New Patients
Principal Investigator: Daniel Lee
last updated: Thu - October 19, 2017 - 06:05 AM
Clinical trial availability changes frequently. Please check this site often for updates or call 312.695.1102 for personal assistance.